Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018681 (
headache
)
56,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phenylpropanolamine
(
PPA
) is contained in about 106 products, over half of which are available over-the-counter (OTC). Most are cough/cold remedies; nine are OTC diet aids. More than nine million Americans were using OTC diet aids in 1981, making
PPA
the fifth most used drug in the United States, responsible for over $200 million in revenues. The safety of
PPA
remains controversial. Although most controlled studies indicate minimal pressor effects with recommended doses, adverse drug reactions (ADRs) continue to be documented. Since 1965, 142 ADRs have been reported in 85 studies, 69% of these in North America. Many such cases may go unrecognized. About two thirds of all ADRs occurred in females and in patients under 30. Of ADRs attributed to legitimately sold
PPA
products, 85% occurred after consumption of OTC products versus only 15% after prescription drugs. The
PPA
product often contained combination ingredients, or
PPA
was consumed along with additional drugs. An overdose of
PPA
was taken in about a third of the cases. After ingestion of non-overdose amounts, 82% of the ADRs were severe. The most frequent side effects involved symptoms compatible with acute hypertension, with severe
headache
the most common complaint. Twenty-four intracranial hemorrhages, eight seizures, and eight deaths (most due to stroke) were associated with
PPA
ingestion. We have summarized these data in an effort to alert clinicians to the prevalence of usage of
PPA
products and the potential for adverse effects. In patients who present with elevated blood pressure or signs of acute hypertension, especially hypertensive encephalopathy of undetermined origin, we recommend inquiry about recent ingestion of
PPA
-containing diet aids and cough/cold products and suggest having such patients remain upright rather than supine.
...
PMID:Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. 220 Feb 64
Phenylpropanolamine
(
PPA
) is the major ingredient in more than 70 over-the-counter preparations including diet pills, nasal decongestants, and the legal "look-alike" stimulants. Structurally and functionally similar to amphetamine and ephedrine,
PPA
has recently been associated with several neurological manifestations including psychosis, stroke, severe
headache
, seizures, and intracerebral hematoma. We report a case of intracerebral hematoma and subarachnoid hemorrhage in a young woman with angiographic and biopsy-proven vasculitis of the central nervous system (CNS) induced by
PPA
in her diet pills. From review of the literature, we distinguish drug-induced vasculitis as a separate entity from primary CNS vasculitis, both clinically and pathologically. This report should alert physicians, in general, to this potentially fatal side effect of
PPA
, a commonly used over-the-counter drug. Also, neurosurgeons in particular should consider the possibility of drug-induced vasculitis when faced with cases of intracerebral or subarachnoid hemorrhage without apparent cause.
...
PMID:Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. 295 31
Hypertension, severe
headache
, and grand mal seizures developed in a 13-year-old girl after ingestion of one nonprescription diet pill containing phenylpropanolamine and caffeine. This case is at least the sixth report of seizures with phenylpropanolamine use in children or adolescents.
Phenylpropanolamine
ingestion must be included in the differential diagnosis of young patients, particularly adolescents, in whom acute neurological symptoms develop.
...
PMID:Phenylpropanolamine-associated CNS complications in children and adolescents. 642 18
Eleven patients had neurologic symptoms after taking "look-alike" pills thought to contain amphetamines but actually containing phenylpropanolamine.
Phenylpropanolamine
, a nonregulated drug, is structurally and functionally similar to amphetamines. Acute onset of
headache
, psychiatric symptoms, or seizures in young patients may be due to phenylpropanolamine use.
...
PMID:Neurologic complications of phenylpropanolamine use. 668 4
Phenylpropanolamine
(
PPA
) is the major ingredient of many over-the-counter cold remedies and diet pills. Use or abuse of
PPA
may cause hemorrhagic stroke or cerebral vasculitis similar to the clinical and angiographic picture associated with amphetamine use or abuse. We report a 32-year-old Taiwanese women who developed sudden onset of severe
headache
, nausea and vomiting on the seventh day of oral ingestion of 75 mg
PPA
per day. Cerebral angiograms showed multiple areas of alternating focal constriction and dilatation ("beading" appearance) in the anterior and posterior cerebral arteries consistent with cerebral arteritis. This case should alert medical practitioners to the potential hazards of over-the-counter drugs like
PPA
.
...
PMID:Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case. 761 35